Marissa Moore
Principal and Vertical Software Lead at OMERS Ventures
Marissa Moore
Principal and Vertical Software Lead at OMERS Ventures
San Francisco Bay Area
Overview
Work Experience
Principal | Vertical Software Lead
2022 - Current
I'm primarily spending time on vertical software/AI defining resilience in public health and safety (e.g., healthcare, life sciences, law enforcement/public safety, national security, etc.), industrial & supply chain (e.g., manufacturing, freight & logistics, etc.), and critical resources & infrastructure (e.g., oil & gas, alt energy, power, utilities, telecom, etc.). OMERS Ventures is the direct, early-stage venture arm of the $127B NAV Canadian pension plan Ontario Municipal Employee Retirement System (OMERS). OMERS manages the pension benefits for 600k municipal workers (e.g., nurses, firefighters, police officers, etc.) in the province of Ontario. We’re currently investing out of our 4th fund, focusing on horizontal B2B software/AI, vertical B2B software/AI, fintech/insurtech, and infrastructure software. We invest in Series A-C rounds with checks ranging in size from $5-25M. Example investments include Shopify, Hopper, Hootsuite, DuckDuckGo, Deliverect, Jobber, Altana, and Mosaic.tech. Under the OMERS umbrella, we also have Growth Equity, Private Equity Buyouts, Infrastructure, Real Estate (Oxford Properties), and Capital Markets strategies.
Managing Analyst - Healthcare
2019 - 2021
Primary focus areas: MedTech & Telehealth
Graduate Teaching Assistant - Biopharmaceutical Strategy
2019 - 2019
AVP, Equity Research
2017 - 2019
Coverage Areas: Industrial Machinery, Cannabis
Director of Business Development
2017 - 2017
AVP, Institutional Equity Sales
2013 - 2017
Passed levels I, II, and III of the Chartered Financial Analyst Program
Molecular Biology Undergraduate Thesis Researcher, Gavis Lab
2011 - 2013
Focus areas: NEUROSCIENCE, GENETICS, CELLULAR DEVELOPMENT ◻ Independently researched & developed methods for screening mRNA asymmetrically localized in D. melanogaster neuromuscular junctions. ◻ Utilized the EP-MS2 method (combining EP transposon insertion with MS2/MCP in vivo fluorescent labeling) to screen for novel localized mRNA transcripts. The goal was to identify which transcripts were asymmetrically localized and then to determine their possible roles in cellular development. ◻ Research was presented as a senior thesis in May of 2013 and was partially included in a scientific publication in G3 Journal in August of 2016 (see publications below).
Global Markets Summer Analyst
2012 - 2012